CFA Basic Science WorkshopDecember 2000 A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information! October 12, 2000
|
| 1:00 PM | Welcome & Introductions |
L. Joel Martinez The Center for AIDS |
| 1:15 PM | Failure of Immunosurveillance in HIV Infection | Judy Lieberman, M.D., Ph.D. Harvard Medical School |
| 1:45 PM | Immune Defects and Immune Reconstitution in HIV Infection | Alan Landay, Ph.D. Rush Presbyterian/ St. Luke's Hospital |
| 2:15 PM | Viral and Cellular Dynamics in HIV Disease: Implications for Therapeutic Immunization | Pat Bucy, M.D., Ph.D. University of Alabama at Birmingham |
| 3:15 PM | Mechanisms of CD8 T Cell Dysfunction in HIV | Dorothy Lewis, Ph.D. Baylor College of Medicine |
| 3:45 PM | Nonviral Vectors for the Treatment of Disease | Nancy Smyth Templeton, Ph.D. Baylor College of Medicine |
| 4:15 PM | Mucosal Immune Responses to Genetic Immunization via Particles | Frank M. Orson, M.D. Veterans Affairs Medical Center |
| 5:00 PM | Roundtable Discussion | Brenda Lein Project Inform and Gregg Gonsalves Treatment Action Group |
| 7:00 PM | Keynote: Priorities in HIV Basic Science Research | Susan Plaeger, Ph.D. Branch Chief, Pathogenesis and Basic Research NIAID, DAIDS |
![]() |
Judy Lieberman, M.D., Ph.D., of Harvard Medical School, fields questions from the audience. |
![]() |
Alan Landay, Ph.D., of Rush Presbyterian/St. Luke's Hospital presents information on immune reconstitution. |
![]() |
Pat Bucy, M.D., Ph.D., of the University of Alabama at Birmingham, explains his views regarding the feasibility of therapeutic immunization for HIV infection. |
![]() |
Dorothy Lewis, Ph.D., of Baylor College of Medicine, describes recent work in her laboratory studying CD8 T cell dysfunction in the setting of HIV. |
![]() |
Genetic immunization using particles was the topic explored by Frank M. Orson, M.D., of the Veteran's Administration Medical Center. |
![]() |
Susan Plaeger, Ph.D., the keynote speaker, addresses the audience over dinner on some new priorities in HIV basic science research. |
![]() |
The presenters for the first CFA Basic Science Workshop (left to right): Susan Plaeger, Ph.D. Pat Bucy, M.D., Ph.D. Dorothy Lewis, Ph.D. Frank M. Orson, M.D. Judy Lieberman, M.D., Ph.D. Nancy Smyth Templeton, Ph.D. Alan Landay, Ph.D. |
Back to the RITA! December 2000 contents page.
A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!
This article was provided by The Center for AIDS. It is a part of the publication Research Initiative/Treatment Action!.
|
|
|
|